
OLD Category: immuno-oncology
October 5, 2020 / J Clin Invest
Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma
October 4, 2020 / Int J Mol Sci
Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models
October 4, 2020 / Mol Ther Oncolytics
Oncolytic Reovirus-Mediated Recruitment of Early Innate Immune Responses Reverses Immunotherapy Resistance in Prostate Tumors
October 3, 2020 / Head Neck Pathol
Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue
September 24, 2020 / Nat Commun
Bone morphogenetic protein 7 promotes resistance to immunotherapy
September 18, 2020 / Nat Cancer
Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response
September 18, 2020 / Exp Ther Med
Evaluation of immune-biomarker expression in high-grade soft-tissue sarcoma: HLA-DQA1 expression as a prognostic marker
September 17, 2020 / JCI Insight
IL-32γ potentiates tumor immunity in melanoma
September 16, 2020 / J Clin Endocrinol Metab
The oncocytic variant of poorly differentiated thyroid carcinoma shows a specific immune-related gene expression profile
September 14, 2020 / Blood
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia
September 14, 2020 / Clin Cancer Res